Welcome to our dedicated page for Destra Multi-Alternative SEC filings (Ticker: DMA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Destra Multi-Alternative Fund (NYSE: DMA) files a range of documents with the U.S. Securities and Exchange Commission as a non-diversified, closed-end management investment company. These SEC filings provide detailed insight into the fund’s governance, policies, and operations, complementing its stated objective of seeking capital appreciation and income with an emphasis on income generation and long-term, non-correlated performance.
Among the key filings are proxy statements on Schedule 14A (DEF 14A), which describe matters submitted to stockholders, such as the election of trustees and changes to fundamental investment policies. Recent definitive proxy statements explain the fund’s proposal to revise its fundamental policy regarding industry concentration, eliminating the requirement to invest over 25% of net assets in the real estate industry. These documents outline the Board of Trustees’ rationale, the role of Destra Capital Advisors LLC and Validex Global Investing, and the voting process for stockholders.
The fund also files current reports on Form 8-K to disclose material events. One such filing reports the results of a special meeting of shareholders where the proposal to revise the concentration policy received the requisite votes for adoption. The 8-K identifies the fund’s common shares registered under Section 12(b) of the Securities Exchange Act of 1934, trading under the symbol DMA on the New York Stock Exchange, and provides the detailed vote counts on the proposal.
On this SEC filings page, users can review these and other regulatory documents, including materials related to the fund’s Amended and Restated Declaration of Trust, term structure, and governance. Stock Titan enhances access to these filings with AI-powered summaries that explain complex sections in straightforward language, highlight the implications of policy changes, and help readers understand how board decisions, proxy proposals, and material events relate to the fund’s alternative investment strategy. Investors can use this resource to follow DMA’s regulatory history, board actions, and shareholder approvals as documented in its official SEC submissions.
Destra Multi-Alternative Fund reported that independent trustee Paul Kazarian has voluntarily resigned from its Board of Trustees. The company said his resignation is effective February 12, 2026, and formally announced the change on February 19, 2026.
The Board thanked Mr. Kazarian for his service and contributions and indicated it will share any future updates on Board composition when appropriate. DMA is a closed-end fund listed on the New York Stock Exchange that focuses on alternative strategies such as real estate, private equity, alternative credit, and hedge strategies.
Destra Multi-Alternative Fund reported the results of a special shareholder meeting held on December 18, 2025. Shareholders voted on a single proposal to revise the Fund’s fundamental investment policy on industry concentration to eliminate its concentration in the real estate industry.
The proposal received 4,285,378 votes for, 1,118,644 votes against, and 16,622 abstentions, with no broker non-votes, and achieved the requisite level of shareholder approval. This means the change to the concentration policy has been adopted, allowing the Fund to adjust its portfolio approach away from a dedicated focus on real estate. The Fund’s common shares continue to trade on the New York Stock Exchange under the symbol DMA.
Destra Multi-Alternative Fund’s 10% owner Saba Capital Management, L.P. reported an insider transaction in the fund’s common stock. On 11/28/2025, the reporting person disposed of 14,496 shares, coded as transaction type J, described as a pro-rata distribution in-kind for no cash consideration. Following this non-cash distribution, the reporting person continues to beneficially own 2,220,648 shares indirectly. The filing is made on behalf of Saba Capital Management, L.P., with signatures by Zachary Gindes and Boaz Weinstein.
Destra Multi-Alternative Fund is calling an Annual Meeting of Stockholders on December 18, 2025 at 9:00 a.m. Mountain Time in Denver, Colorado. Stockholders of record as of November 14, 2025 are being asked to elect two Class I Trustees, John S. Emrich and Michael S. Erickson, to terms running to the 2028 annual meeting, and the Board unanimously recommends voting FOR both nominees.
The Fund’s Board is divided into three staggered classes and is composed entirely of Independent Trustees, supported by Audit, Nominating and Governance, and Qualified Legal Compliance Committees. The Audit Committee oversaw the March 31, 2025 financial statements and reported audit fees of $145,000 and tax fees of $8,500 for Cohen & Company, Ltd. As of September 30, 2025, Saba Capital Management, L.P. beneficially owned 2,235,144 shares, or 24.94% of the Fund’s 8,963,239 outstanding common shares.
Destra Multi-Alternative Fund called a Special Meeting to seek stockholder approval to revise its fundamental concentration policy so the Fund would no longer be required to invest over 25% of net assets in real estate. The Board of Trustees unanimously recommends voting FOR the proposal.
The meeting is set for December 18, 2025 at 9:00 a.m. MT at PINE Advisor Solutions in Denver. Stockholders of record on November 10, 2025 may vote. Approval requires a “majority of the outstanding voting securities” as defined by the 1940 Act. The Fund had 8,963,239 shares outstanding as of November 10, 2025.
The Board cited greater flexibility to pursue attractive opportunities as the rationale. Proxy solicitation is being handled by EQ Fund Solutions with estimated fees of $15,725. Exhibit A lists significant holders, including Saba Capital Management at 24.94% beneficial ownership.
Destra Multi-Alternative Fund (DMA) reported insider purchases by its President, Robert A. Watson, on 10/31/2025. The Form 4 lists three open‑market buys: 176 shares at $8.61 (direct), 56 shares at $8.61 (indirect by spouse), and 606 shares at $8.62 (indirect by 401(k) plan).
Following these transactions, beneficial ownership amounts shown were 15,335.939 shares direct, 15,391.939 shares indirect by spouse, and 15,997.939 shares indirect via the 401(k) plan. The filing indicates the reporter is an Officer (President) and is filed for one reporting person.
Absolute Investment Advisers, LLC filed Amendment No. 2 to Schedule 13G reporting its beneficial ownership in Destra Multi-Alternative Fund common stock. The firm disclosed beneficial ownership of 286,632 shares, representing
The filer reported sole voting power and sole dispositive power over 286,632 shares, with no shared voting or dispositive power. The filing notes ownership of 5 percent or less of the class. The reporting person is classified as an investment adviser (IA).
Destra Multi Alternative Fund (DMA): Schedule 13G/A filed by Bulldog Investors, LLP, Phillip Goldstein, and Andrew Dakos reporting beneficial ownership as of September 30, 2025.
Bulldog Investors, LLP reports 280,192 shares with 3.13% of the class, with shared voting and dispositive power and no sole power. Phillip Goldstein reports 322,457 shares representing 3.6%, with shared voting and dispositive power and no sole power. Andrew Dakos reports 280,192 shares at 3.13%, also with shared voting and dispositive power and no sole power.
The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. Clients of Bulldog Investors and other accounts for which Messrs. Dakos and/or Goldstein are deemed beneficial owners are entitled to receive dividends and sales proceeds.
Insiders purchased shares of Destra Multi-Alternative Fund (DMA). Saba Capital Management, L.P. reported acquiring 68,449 shares on 09/09/2025 at $8.60 per share. After the transaction, the reporting parties beneficially owned 2,235,144 shares indirectly. The Form 4 lists Saba Capital and Boaz Weinstein as reporting persons and identifies them as directors and 10% owners.
Schedule 13D/A Amendment No. 12 discloses that Saba Capital Management, L.P., Saba Capital Management GP, LLC and Boaz R. Weinstein (together, the Reporting Persons) beneficially own 2,235,144 common shares of Destra Multi-Alternative Fund (ticker DMA), representing 24.94% of the 8,963,239 shares outstanding as of March 31, 2025. The Reporting Persons report shared voting and dispositive power over these shares and state approximately $15,109,969 was paid to acquire the reported position, funded from investor subscription proceeds, capital appreciation and margin borrowings. No new purpose for the holdings is reported and no contracts or arrangements concerning the securities are disclosed. Recent open-market transactions from the prior 8/18/25 filing through 9/9/25 are referenced and incorporated by Schedule A.